Cardiology

Study: Type 2 diabetes pill Jardiance cuts risk of death

Jardiance sharply reduced chances of dying in diabetic patients at high risk of heart complications, a study shows, making the Type 2 diabetes medication the first shown to lengthen diabetics' lives.

Cardiology

New mineralocorticoid receptor antagonist for heart failure

In heart failure patients with diabetes and/or chronic kidney disease, a new, non-steroidal mineralocorticoid receptor antagonist (MRA) called finerenone was no more effective than the currently approved MRA eplerenone in ...

Cardiology

Zinc at the heart of new study

Zinc plays an important role in regulating heartbeat, according to new research led by the University of St Andrews.

Cardiology

Amyloid scan of the heart predicts major cardiac events

Amyloid build-up is commonly talked about in relation to Alzheimer's disease, but amyloidosis can be found throughout the body. An excessive accumulation of these insoluble proteins could cause a heart attack or even death. ...

Diseases, Conditions, Syndromes

Score IDs patients with upper extremity DVT at low risk

(HealthDay)—For patients with upper-extremity deep vein thrombosis (DVT), six easily available factors can be used to create a score that identifies those at low risk of adverse events during the first week, according to ...

Cardiology

Cognitive impairment predicts worse outcome in heart failure

Cognitive impairment predicts worse outcome in elderly heart failure patients, reveals research presented today at Heart Failure 2015 by Hiroshi Saito, a physiotherapist at Kameda Medical Centre in Kamogawa, Japan. Patients ...

Cardiology

Time is muscle in acute heart failure

Urgent diagnosis and treatment in acute heart failure has been emphasised for the first time in joint recommendations published today in European Heart Journal.

page 23 from 33